Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

This study has been completed.
Information provided by:
Tehran University of Medical Sciences Identifier:
First received: April 17, 2007
Last updated: NA
Last verified: April 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):